Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
Quick Stats
Jun 23, 202664.6
AI Score
BUY1.61
Volume Ratio
Aug 04, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
RYTM Stock Summary
Last updated Jun 23, 2026
RYTM is currently trading at $106.19, positioned above its 200-day moving average of $97.79, indicating a long-term uptrend. The stock has a 52-week range of $60.8 to $122.2.
Technical Analysis: The 50-day moving average stands at $89.1, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 73.967, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.041, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RYTM at 64.6/100 with a BUY recommendation.
RYTM (Rhythm Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Jun 23, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 73.967 |
| CMF (20) | -0.041 |
| ROC (10) | 23.247 |
| ADX (14) | 24.232 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 2.887 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -1.256 |
| MFI (14) | 83.74 |
RYTM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RYTM Price vs Max Options Open Interest
RYTM Max Change In Options Open Interest
RYTM Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RYTM Daily Out of Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RYTM Daily In the Money Options - Sort by Max open Interest (near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RYTM Most Active Options by Volume(near term)
23rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Rhythm Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RYTM Moving Averages Analysis
Rhythm Pharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026
Rhythm Pharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026
RYTM (Rhythm Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 23, 2026
| Days | MA |
|---|---|
| 10 | 92.92 |
| 20 | 90.43 |
| 30 | 90.26 |
| 50 | 89.1 |
| 100 | 91.2 |
| 200 | 97.79 |
RYTM Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.2 billion |
| Earnings/Share ($) | -3.13 |
| Net Proft Margin (%) | -0.9333 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.2576 |
| EPS Estimate Next Year ($) | -0.7414 |
| WallStreet Target Price ($) | 139.4667 |
| Most Recent Quarter |